C
CELC
Celcuity Inc
138.23
-4.30-3.02%After Hours: 138.32 +0.09 +0.07%18:53 05/22 EDT
OPEN/PREV CLOSE140.85/138.23
TODAY RANGE132.85-140.85
VOL687.49K
MARKET CAP6.55B
52 WEEK RANGE10.26-151.02
AVG VOL (3M)912.55K
% TURNOVER1.41%
TURNOVER--
P/E (TTM)-34.4681
% RANGE5.79%
EPS(TTM)-3.8952
P/E(FORWARD)-33.0690
P/B121.27
BVPS1.107
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP5.46B
SHARES OUTSTANDING48.77M
NEXT EARNINGS08/12-08/17
FREE FLOAT40.67M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·4d ago
Citizens biotech analysts hold a dinnermeeting at ASCO
TipRanks·6d ago
Celcuity’s Gedatolisib Shines Amid Mounting Cash Burn
TipRanks·05/18 20:48
Celcuity Shareholders Approve New 2026 Equity Incentive Plans
Dow Jones·05/18 10:30
Celcuity Price Target Raised to $185.00/Share From $165.00 by HC Wainwright & Co.
Dow Jones·05/18 10:30
Celcuity Is Maintained at Buy by HC Wainwright & Co.
Benzinga·05/18 10:22
HC Wainwright & Co. Maintains Buy on Celcuity, Raises Price Target to $185
TipRanks·05/18 10:05
Celcuity price target raised to $185 from $165 at H.C. Wainwright
TipRanks·05/16 00:13
Celcuity’s Earnings Call: Strong Data, Rising Cash Burn
Benzinga·05/15 17:13
Celcuity's Cancer Drug Expansion Could Ignite Massive New Market Opportunity: Analyst
TipRanks·05/15 13:21
Celcuity price target raised to $175 from $150 at Stifel
Dow Jones·05/15 13:19
Celcuity Is Maintained at Overweight by Wells Fargo
Benzinga·05/15 13:08
Wells Fargo Maintains Overweight on Celcuity, Raises Price Target to $183